ABL Diagnostics annonce l’initiation de couverture de son titre par In Extenso Finance
- ABL Diagnostics Agreement: ABL Diagnostics signed an agreement with In Extenso Finance for coverage and monitoring of its stock, with a strong buy recommendation and a target price of €6.01.
- Collaboration Purpose: The collaboration aims to enhance ABL Diagnostics' visibility in the stock market and demonstrate transparency efforts to all stakeholders.
- Coverage Initiation: In Extenso Finance's coverage initiation can be viewed on their website and ABL Diagnostics' website.
- About ABL Diagnostics: ABL Diagnostics specializes in developing software for medical data collection, quality measurement, genotyping infectious diseases, and decision support for healthcare professionals and researchers.
- Stock Listing: ABL Diagnostics is listed on the Euronext compartment B market of NYSE EURONEXT with the ISIN code FR001400AHX6.
Trade with 70% Backtested Accuracy
Analyst Views on ABLD
About the author
ULTY, ABLD: Significant Withdrawals from ETFs
ETF Outflow Details: The ABLD ETF experienced the largest outflow, losing 700,000 units, which is a 34.1% decrease in outstanding units compared to the previous week.
Source of Information: The views expressed in the article are those of the author and do not necessarily represent the opinions of Nasdaq, Inc.
Shell Pauses Rotterdam Biofuels Initiative Following Cost Assessment
Shell Halts Biofuels Project: Shell Nederland Raffinaderij B.V. has decided to stop plans to resume construction of its biofuels facility in Rotterdam after determining it would not be competitive enough to meet market demands for affordable, low-carbon products.
Continued Investment in Energy Transition: Despite halting the biofuels project, Shell remains committed to the Netherlands, having invested 6.5 billion euros in various energy transition initiatives, including CO₂ storage and renewable hydrogen development.
Shell Boosts Nigerian Deepwater Assets With TotalEnergies Stake Purchase
Shell's Acquisition: Shell Nigeria Exploration has agreed to acquire TotalEnergies' 12.5% interest in the OML 118 Production Sharing Contract for $510 million, increasing its ownership from 55% to 67.5%, aligning with its goal of growing production by 1% annually until 2030.
TotalEnergies' Strategy Shift: The sale is part of TotalEnergies' strategy to optimize its Upstream portfolio by focusing on low-cost, low-emission assets, while also progressing projects like Ubeta to sustain gas supply in Nigeria.
Shell Chemical Division Sale To Improve Bottom Line: Analyst
Shell PLC Earnings Report: Shell reported first-quarter revenue of $69.234 billion, missing expectations, but adjusted earnings per ADS of $1.84 exceeded consensus. The company anticipates cash capital expenditures of $20-$22 billion for 2025 and stable production levels for the second quarter.
Analyst Outlook: RBC Capital Markets analyst Biraj Borkhataria maintains an Outperform rating on Shell, citing a strong balance sheet and ongoing share repurchase program that should enhance long-term earnings growth. He also notes planned divestments in Nigeria and the Chemicals division as positive steps for cost reduction and profitability improvement.
Shell Q1 Profit Jumps 52%, Launches $3.5 Billion Stock Buyback
First Quarter Results: Shell plc reported a revenue of $69.234 billion, which fell short of expectations, but adjusted earnings increased by 52% to $5.58 billion, and net income rose significantly to $4.78 billion. The company also announced a $3.5 billion share buyback program and declared a dividend of $0.358 per share.
Future Guidance: For the second quarter of 2025, Shell expects production levels to be lower than previous quarters, with Integrated Gas production projected at 890 – 950 thousand boe/d and Upstream at 1,560 – 1,760 thousand boe/d. Additionally, corporate adjusted earnings are anticipated to be a net expense of $400 – $600 million.
Shell Lowers Q1 Production Outlook, Flags Write-Offs And Maintenance
Production Outlook Revision: Shell PLC has lowered its first-quarter production guidance for Integrated Gas and Upstream segments due to unplanned maintenance and the completion of a divestment, leading to a decrease in expected output across various categories.
Financial Adjustments and Stock Performance: The company has raised its cost reduction target and plans to increase shareholder distributions while experiencing a 4.80% drop in stock price during premarket trading.
ULTY, ABLD: Significant Withdrawals from ETFs
ETF Outflow Details: The ABLD ETF experienced the largest outflow, losing 700,000 units, which is a 34.1% decrease in outstanding units compared to the previous week.
Source of Information: The views expressed in the article are those of the author and do not necessarily represent the opinions of Nasdaq, Inc.
Shell Pauses Rotterdam Biofuels Initiative Following Cost Assessment
Shell Halts Biofuels Project: Shell Nederland Raffinaderij B.V. has decided to stop plans to resume construction of its biofuels facility in Rotterdam after determining it would not be competitive enough to meet market demands for affordable, low-carbon products.
Continued Investment in Energy Transition: Despite halting the biofuels project, Shell remains committed to the Netherlands, having invested 6.5 billion euros in various energy transition initiatives, including CO₂ storage and renewable hydrogen development.
Shell Boosts Nigerian Deepwater Assets With TotalEnergies Stake Purchase
Shell's Acquisition: Shell Nigeria Exploration has agreed to acquire TotalEnergies' 12.5% interest in the OML 118 Production Sharing Contract for $510 million, increasing its ownership from 55% to 67.5%, aligning with its goal of growing production by 1% annually until 2030.
TotalEnergies' Strategy Shift: The sale is part of TotalEnergies' strategy to optimize its Upstream portfolio by focusing on low-cost, low-emission assets, while also progressing projects like Ubeta to sustain gas supply in Nigeria.
Shell Chemical Division Sale To Improve Bottom Line: Analyst
Shell PLC Earnings Report: Shell reported first-quarter revenue of $69.234 billion, missing expectations, but adjusted earnings per ADS of $1.84 exceeded consensus. The company anticipates cash capital expenditures of $20-$22 billion for 2025 and stable production levels for the second quarter.
Analyst Outlook: RBC Capital Markets analyst Biraj Borkhataria maintains an Outperform rating on Shell, citing a strong balance sheet and ongoing share repurchase program that should enhance long-term earnings growth. He also notes planned divestments in Nigeria and the Chemicals division as positive steps for cost reduction and profitability improvement.
Shell Q1 Profit Jumps 52%, Launches $3.5 Billion Stock Buyback
First Quarter Results: Shell plc reported a revenue of $69.234 billion, which fell short of expectations, but adjusted earnings increased by 52% to $5.58 billion, and net income rose significantly to $4.78 billion. The company also announced a $3.5 billion share buyback program and declared a dividend of $0.358 per share.
Future Guidance: For the second quarter of 2025, Shell expects production levels to be lower than previous quarters, with Integrated Gas production projected at 890 – 950 thousand boe/d and Upstream at 1,560 – 1,760 thousand boe/d. Additionally, corporate adjusted earnings are anticipated to be a net expense of $400 – $600 million.
Shell Lowers Q1 Production Outlook, Flags Write-Offs And Maintenance
Production Outlook Revision: Shell PLC has lowered its first-quarter production guidance for Integrated Gas and Upstream segments due to unplanned maintenance and the completion of a divestment, leading to a decrease in expected output across various categories.
Financial Adjustments and Stock Performance: The company has raised its cost reduction target and plans to increase shareholder distributions while experiencing a 4.80% drop in stock price during premarket trading.
